Manipal Well being Enterprises Ltd, a Bengaluru-based conglomerate backed by Singapore’s state-run funding agency Temasek, on Tuesday filed its draft Crimson Herring Prospectus (DRHP) with SEBI to lift Rs 8,000 crore by way of an IPO.
The IPO has a face worth of £2, with a brand new challenge measurement of Rs 8,000 crore, with as much as 43,227,668 shares to be supplied by promoters Imperius Healthcare Investments, Manipal Training, Medial Group India, and current traders together with TPG and Novo Holdings.
The proceeds from the first financing might be primarily used for debt repayments, with Rs 5,378 crore being utilized for full or partial reimbursement of sure excellent borrowings and accrued curiosity thereof availed by one of many firm’s main subsidiaries, Manipal Hospitals Ltd, Rs 574 crore for buying a minority stake in Sahyadri Hospitals, the corporate’s exited subsidiary, and the remaining funds for basic company functions, market sources mentioned.
The corporate could take into account a pre-IPO placement of as much as Rs 1,600 crore in session with the lead supervisor working the books.
The supply might be made by way of a bookbuilding course of, with a minimal of fifty% of the online supply being allotted to certified institutional patrons, a minimal of 15% of the online supply being allotted to non-institutional bidders and a minimal of 35% of the online supply to particular person non-public bidders.
